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ABSTRACT
While rapid on-site evaluation (ROSE) is considered to be an additional tool to optimize
the yield of tissue acquisition during EUS-guided FNA of the gastrointestinal tract,1,2
it is not readily available at all times while performing these procedures. We reviewed
twenty-seven EUS-guided FNA procedures done at our institution in Tripoli central
hospital with general working center restrictions due to local COVID-19 prevention protocols. Approximately 92.6 % of tissue adequacy was achieved despite the lack of ROSE
which is comparable to ROSE-based tissue acquisition results. This is a small-size retrospective chart review study to illustrate the optimal tissue adequacy during EUS-guided
FNA of the upper gastrointestinal tract in a suboptimal hospital setting, lack of ROSE
and merely utilizing visual inspection of those specimens by the performing physician
and its effects on the diagnosis.
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INTRODUCTION
The Endoscopic Ultrasound (EUS) machine is a combination of an endoscope with an ultrasound device
that has been used in the diagnostic and therapeutic
assessment of the gastrointestinal system and has
changed the approach of gastrointestinal pathologies
in modern medicine.3 Endoscopic ultrasound-guided-fine needle aspiration (EUS-guided FNA) is now
performed routinely in many advanced endoscopy
centers around the globe and has enhanced the ability to diagnose pancreatic pathologies.4 The development of linear ultrasound endoscopes led to EUS-FNA
being carried out with great precision in real-time,
with the FNA needle being visualized throughout
the procedure. It has been found that EUS-guided
FNA is most useful in making an initial tissue diagnosis of malignancy, carrying a high diagnostic value
with a low complication rate. It is also cost-effective
in accurately preoperatively staging patients with
pancreatic solid masses and has greatly improved the
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prognosis by reducing unnecessary surgical interventions and eventual morbidity and mortality in
patients with advanced cancer.6,7 Early diagnosis of
pancreatic tumors is essential to identifying patients
who are eligible for surgical intervention. Therefore,
EUS-guided FNA is considered an important tool,
since it is capable of identifying neoplasms less than
3mm that are rarely noticed by other imaging modalities.10 EUS-guided FNA also has limitations, however,
and imperfections,3 as the utility of EUS in obtaining
pancreatic samples or tissue of any gastrointestinal
pathology depends on multiple factors. These include
the physician’s experience and training and adequate
supervision and rapid on-site evaluation (ROSE),
which provides a real-time evaluation of the acquired
specimen. Furthermore, needle size, patient sedation,
patient age, past medical history, and the location,
size, and consistency of the lesion must all be considered.
A medical literature review to evaluate the role of
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EUS-guided FNA for diagnosis of solid pancreatic
masses showed 78-95% sensitivity, 75-100% specificity, 98-100% positive predictive value, 46-80% negative predictive value (NPV), and 78-95% accuracy.
The reported complications rate of EUS-guided FNA
for pancreatic solid masses was 0-2%, although the
criteria for complications varied among the studies.7
METHOD
This is a retrospective chart review of 27 patients that
had undergone FNA-guided EUS from the beginning
of March until the end of August 2020. These cases
occurred during the COVID-19 pandemic, which
meant that ROSE was not being used during the
evaluation of these patients. Our histopathology
department provided histological reports for all of
the EUS-guided FNA samples, which were read by
the same histopathologists. Descriptive analysis and
cross-tabulation were done using SPSS.
LIMITATIONS
This study reviewed a retrospective chart, as opposed
to conducting randomized control trials, which is
known to have more reliable results. A larger cohort
of the reviewed cases, instead of the actual used
number, would have more definitively assessed the
small differences in diagnostic yield and allowed a
better understanding of the reliability and enhanced
measurement quality of the tissues acquired. Due
to the pandemic prevention protocol in our center,
several EUS cases were postponed. Additionally, there
were several technical and clinical obstacles during
those procedures, including the unavailability of an
anesthesiologist physician or CRNA, an absence of
staff training on the EUS machinery, and assistance
techniques which forced the operator to multitask
while performing those procedures.
DISCUSSION
All procedures were done in a tertiary center located
in Tripoli and were performed by a trained Libyan
physician in collaboration with a qualified U.S. physician. FNAs were obtained using both the standard
and fanning techniques, with and without suction,
using a 20cc syringe. No adverse events were reported during or immediately after those procedures.
Patient ages ranged between 18 and 77 years old
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with a mean age of 55 years, with gender distribution
showing an almost equal representation of male and
female patients.
The vast majority of specimens were collected using
22-gauge needles, with 19-gauge needles also being
used. All of the samples were collected in both
containers and slides which were air-dried on site. All
samples were visually inspected by the operator to
assess tissue adequacy before they were eventually
sent to the histopathology laboratory and ultimately
analyzed by three experienced histopathologists.
Among the 42 patients who were required to undergo a EUS evaluation as a result of prior imaging findings that necessitated further evaluation, EUS-guided FNA was done for only 28 of them. Out of those
28 cases, we were able to collect 27 results, as we
were unable to follow up with one patient. Within
those 27 specimens, 21 were confirmed to be adenocarcinomas. All 21 of those patients were referred to
an oncologist for further management.
In terms of tissue acquisition, all of the 27 specimens
contained sufficient tissue. As most of the patients
that received EUS-guided FNA had radiological findings that suggested malignancy, FNA results showed
a sensitivity of 77.8% and a positive predictive value
of 100%. Six results were considered to be inconclusive as the histopathology reports did not match the
radiological findings or the surgical biopsy results,
even though those tissue specimens were adequate.
Among the 27 specimens, 25 (92%) of them were in
both conventional smears and cell block samples.
The remaining two specimens contained only cells
as noted by the conventional smear method (8%).
One specimen that was obtained from the gallbladder was inconclusive, while the other one was
confirmed to be malignancy of the pancreatic head.
This confirms the significance of the tissue obtaining
technique implemented throughout the procedure.
According to the histopathology results, the most
identified neoplasm was adenocarcinoma (40+%). Almost 20% of the diagnosed cases were undifferentiated malignant epithelial neoplasms. There was only
one sample that had extensive cellular destruction
during preparation.
25-gauge needles are considered the most optimal
recommended needle size for the sampling of pancreatic masses and are known to have a higher neg-
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ative predictive value and cause less tissue damage
than standard 22-gauge needles.5 The majority of our
specimens were collected using 22-gauge needles,
although 19-gauge needles were also used.
One prospective randomized study 8 aimed to compare the diagnostic yield of 22-gauge and 25-gauge
needles. It was found that cytology was diagnostic in
91.6% of cases, while no statistically significant differences were found between the two groups when
a similar number of passes were performed in both
arms.8 Our study suggests similar findings to those in
the above study.
It has been explained that EUS-guided FNA is limited
by the lack of cytology expertise. It has also been
foreseen that EUS-guided fine needle biopsy (FNB)
may likely overcome these limitations by moving the
practice of EUS from cytology to histology, which will
result in expanding the use of EUS and facilitating
targeted therapies and treatment monitoring.9
CONCLUSION
We concluded that our results of tissue acquisition
and analysis with the standard (off-site) histopathology techniques are comparable to those in more
developed centers where ROSE is readily available.
Although the site in Tripoli lacked high-standard
training and experienced a significant shortage of
properly equipped facilities, most of the patients
who received management in our care provided
adequate tissue samples collected mainly using
22-gauge needles with results that confirm or
exclude neoplasms. According to the previously
presented data, with consideration of the working
clinical conditions, our results retained reliability of
sample acquisition and efficacy in the detection of
pancreatic and hepatobiliary tumors. We suggest
that ROSE is a helpful tool, but may not be necessary
in the presence of an experienced physician.
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